A phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan clinical oncology group study JCOG1002

Japanese Journal of Clinical Oncology

Volumn 42, Issue 6, 2012, Pages 556-559

  Katayama, Hiroshi ^a   Ito, Seiji ^b   Sano, Takeshi ^c   Takahari, Daisuke ^b   Mizusawa, Junki ^a   Boku, Narikazu ^d   Tsuburaya, Akira ^e   Terashima, Masanori ^f   Sasako, Mitsuru ^g  

^a NATIONAL CANCER CENTER   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KANAGAWA CANCER CENTER   (Japan)

^f SHIZUOKA CANCER CENTER   (Japan)

^g HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Extensive lymph node metastasis; Gastric cancer; Phase II; Preoperative chemotherapy

Indexed keywords

CISPLATIN; DOCETAXEL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELIAC ARTERY; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; DRUG EFFICACY; DRUG SAFETY; GASTRECTOMY; HEPATIC ARTERY; HISTOLOGY; HUMAN; LAPAROSCOPY; LYMPH NODE METASTASIS; NOTE; PARAAORTIC LYMPH NODE; PHASE 2 CLINICAL TRIAL; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PROPER HEPATIC ARTERY; SPLEEN ARTERY; STOMACH CANCER; STUDY DESIGN; SUPERIOR MESENTERIC VEIN; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR GROWTH;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AORTA; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DRUG COMBINATIONS; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; OXONIC ACID; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TAXOIDS; TEGAFUR; TREATMENT OUTCOME;

EID: 84862246534     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hys054     Document Type: Note

References (9)

1. Yoshikawa T, Sasako M, Yamamoto S, et al. Phase II study neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Sur 2009;96:1015-22.
2. Yoshikawa T, Nakamura K, Tsuburaya A, et al. A phase II study of preoperative chemotherapy with S-1 and cisplatin followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis: survival results of JCOG0405. Am Soc Clin Oncol 2011 (Gastrointestinal Cancers Symposium Abstract No. 70).
3. Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008;359:453-62.
4. Sasako M, Mcculloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995;82:346-51.
5. Van Cutsem E, Moiseyenko VM, Tjulandin S, et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 2006;24: 4991-7.
6. Sato Y, Takayama T, Sagawa T, et al. Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer. Cancer Chemother Pharmacol 2010;66: 721-8.
7. Fushida S, Fujimura T, Oyama K, Yagi Y, Kinoshita J, Ohta T. Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin, and S-1 in gastric cancer patients with para-aortic lymph node metastases. Anticancer Drugs 2009;20:752-6.
8. Nakayama N, Koizumi W, Sasaki T, et al. A multicenter, phase I dose-escalating study of docetaxel, cisplatin and S-1 for advanced gastric cancer (KDOG0601). Oncology 2008;75:1-7.
9. Koizumi W, Nakayama N, Tanabe S, et al. A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601). Cancer Chemother Pharmacol 2012;69:407-13.